| Literature DB >> 32566768 |
Brian Liszewski1,2.
Abstract
INTRODUCTION: The term near miss implies the aversion of a harm event but often there is a lack of evidence when establishing a link between a failure in process and potential harm. The focus of this study was to use reported incident data to inform a prioritization framework for the triage of near miss events in a radiation therapy program.Entities:
Keywords: Failure modes; Incident learning; Near miss; Quality; Radiation therapy; Safety
Year: 2020 PMID: 32566768 PMCID: PMC7296427 DOI: 10.1016/j.tipsro.2020.04.001
Source DB: PubMed Journal: Tech Innov Patient Support Radiat Oncol ISSN: 2405-6324
Criteria and sub-criteria for analytic hierarchy process prioritization.
| Criteria | Failure May Occur | Potential Impact | Failure Would Go Undetected |
|---|---|---|---|
| Sub-Criteria 1 | 0–15% of program incidents | No harm patient is asymptomatic and no treatment is required. | Event was detected because it was undeliverable |
| Sub-Criteria 2 | 16–30% of program incidents | Mild symptoms, if present, are mild; no or minimal intervention (observation, investigation, minor treatment) is required; harm or loss of function is minimal or intermediate but short term. | Event was detected at 1st QA |
| Sub-Criteria 3 | 31–45% of program incidents | Moderate patient is symptomatic, requiring intervention (additional treatment or operative procedure) or a prolonged hospital stay; long-term or permanent harm or loss of function. | Event was detected at pre-treatment QA |
| Sub-Criteria 4 | 46–60% of program incidents | Severe patient is symptomatic, requiring life-saving intervention or a major surgical/medical intervention; shortened life expectancy or major long-term or permanent harm or loss of function. | Event was detected at on-treatment QA |
| Sub-Criteria 5 | 61–75% of program incidents | Death on the balance of probabilities, death was caused or brought forward in the short term by the incident. | Treatment delivery |
| Sub-Criteria 6 | 76–90% of program incidents | Event was detected at sporadic QA | |
| Sub-Criteria 7 | 91–100% of program incidents |
Fig. 1Thematic analysis: Near miss and actual event classification.
Near miss events by barrier step.
| Barrier Step | # of Events |
|---|---|
| Undeliverable | 20 |
| 1st QA | 9 |
| Pre-Treatment QA | 16 |
| On-Treatment QA | 11 |
| Treatment Delivery | 4 |
| Sporadic QA | 0 |
Event classification by criteria and normalized 10 point score.
| Event # | Event Type | Failure May Occur | Potential Impact | Failure Would Go Undetected | Normalized 10 Point Score |
|---|---|---|---|---|---|
| Actual | Fractionation Issues | 0–15% | Mild | Sporadic QA | 4 |
| Actual | Accessory Issue | 0–15% | Mild | Sporadic QA | 4 |
| Actual | Protocol Not Followed | 0–15% | Mild | Sporadic QA | 4 |
| Actual | Tx Technique Not Completed | 0–15% | Mild | Sporadic QA | 4 |
| Near Miss | Wrong Setup | 0–15% | Moderate | Treatment Delivery | 4 |
| Near Miss | F/S Error | 0–15% | Mild | 1st QA | 1 |
| Near Miss | Referencing | 46–60% | Mild | Undeliverable | 1 |
| Near Miss | Mislabeled | 16–30% | No Harm | Pre-Treatment | 1 |
| Near Miss | Accessory | 0–15% | No Harm | Pre-Treatment | 1 |
| Near Miss | Patient Related Circumstances | 0–15% | Mild | Undeliverable | 1 |
| Near Miss | Mislabeled | 16–30% | No Harm | 1st QA | 1 |
| Near Miss | Mislabeled | 16–30% | No Harm | Undeliverable | 1 |
| Near Miss | Incorrect Iso Slice Marked | 0–15% | No Harm | Undeliverable | 1 |
| Near Miss | Sites Omitted | 0–15% | No Harm | Undeliverable | 1 |
| Near Miss | Accessory | 0–15% | No Harm | Undeliverable | 1 |
| Near Miss | Undeliverable | 0–15% | No Harm | Undeliverable | 1 |
| Near Miss | Tattoo Cannot be Found | 0–15% | No Harm | Undeliverable | 1 |
| Near Miss | Reference Image Omitted | 0–15% | No Harm | Undeliverable | 1 |
| Near Miss | F/S Error | 0–15% | Mild | 1st QA | 1 |
| Near Miss | Referencing | 46–60% | Mild | Undeliverable | 1 |
| Near Miss | Mislabeled | 16–30% | No Harm | Pre-Treatment | 1 |
| Near Miss | Accessory | 0–15% | No Harm | Pre-Treatment | 1 |
| Item | Failure may occur | Potential Impact | Failure would go undetected |
|---|---|---|---|
| Failure may occur | 1 | 0.166666667 | 0.25 |
| Potential Impact | 6 | 1 | 2 |
| Failure would go undetected | 4 | 0.5 | 1 |
| SUM | 11 | 1.666666667 | 3.25 |
| Item | Failure may occur | Potential Impact | Failure would go undetected | Weight |
|---|---|---|---|---|
| Failure may occur | 0.090909091 | 0.1 | 0.076923077 | |
| Potential Impact | 0.545454545 | 0.6 | 0.615384615 | |
| Failure would go undetected | 0.363636364 | 0.3 | 0.307692308 |
| Item | 0–15% | 16–30% | 31–45% | 46–60% | 61–75% | 76–90% | 91–100% |
|---|---|---|---|---|---|---|---|
| 0–15% | 1 | 0.25 | 0.2 | 0.166667 | 0.142857 | 0.125 | 0.111111 |
| 16–30% | 4 | 1 | 0.25 | 0.2 | 0.166667 | 0.142857 | 0.125 |
| 31–45% | 5 | 4 | 1 | 0.25 | 0.2 | 0.166667 | 0.142857 |
| 46–60% | 6 | 5 | 4 | 1 | 0.25 | 0.2 | 0.166667 |
| 61–75% | 7 | 6 | 5 | 4 | 1 | 0.25 | 0.2 |
| 76–90% | 8 | 7 | 6 | 5 | 4 | 1 | 0.25 |
| 91–100% | 9 | 8 | 7 | 6 | 5 | 4 | 1 |
| SUM | 40 | 31.25 | 23.45 | 16.61667 | 10.75952 | 5.884524 | 1.995635 |
| Item | 0–15% | 16–30% | 31–45% | 46–60% | 61–75% | 76–90% | 91–100% | Weight |
|---|---|---|---|---|---|---|---|---|
| 0–15% | 0.025 | 0.01 | 0.00853 | 0.01003 | 0.01327 | 0.02124 | 0.05568 | |
| 16–30% | 0.1 | 0.03 | 0.01066 | 0.01203 | 0.01549 | 0.02428 | 0.06263 | |
| 31–45% | 0.125 | 0.12 | 0.04264 | 0.01505 | 0.01859 | 0.02832 | 0.07159 | |
| 46–60% | 0.15 | 0.16 | 0.17057 | 0.06018 | 0.02324 | 0.03399 | 0.08351 | |
| 61–75% | 0.175 | 0.19 | 0.2132 | 0.24072 | 0.09294 | 0.04248 | 0.10022 | |
| 76–90% | 0.2 | 0.22 | 0.25586 | 0.30090 | 0.37176 | 0.16993 | 0.12527 | |
| 91–100% | 0.225 | 0.25 | 0.29850 | 0.36108 | 0.46470 | 0.67975 | 0.50109 |
| Item | No Harm | Mild | Moderate | Severe | Death |
|---|---|---|---|---|---|
| No Harm | 1 | 0.25 | 0.2 | 0.166667 | 0.142857 |
| Mild | 4 | 1 | 0.25 | 0.2 | 0.166667 |
| Moderate | 5 | 4 | 1 | 0.25 | 0.2 |
| Severe | 6 | 5 | 4 | 1 | 0.25 |
| Death | 7 | 6 | 5 | 4 | 1 |
| SUM | 23 | 16.25 | 10.45 | 5.616667 | 1.759524 |
| Item | No Harm | Mild | Moderate | Severe | Death | Weight |
|---|---|---|---|---|---|---|
| No Harm | 0.043478 | 0.015385 | 0.019139 | 0.029674 | 0.081191 | |
| Mild | 0.173913 | 0.061538 | 0.023923 | 0.035608 | 0.094723 | |
| Moderate | 0.217391 | 0.246154 | 0.095694 | 0.04451 | 0.113667 | |
| Severe | 0.26087 | 0.307692 | 0.382775 | 0.178042 | 0.142084 | |
| Death | 0.304348 | 0.369231 | 0.478469 | 0.712166 | 0.568336 |
| Item | Undeliverable | 1st QA | Pre-Treatment QA | On-Treatment QA | Treatment Delivery | Sporadic QA |
|---|---|---|---|---|---|---|
| Undeliverable | 1 | 0.25 | 0.2 | 0.166667 | 0.2 | 0.166667 |
| 1st QA | 4 | 1 | 0.25 | 0.2 | 0.166667 | 0.142857 |
| Pre-Treatment QA | 5 | 4 | 1 | 0.25 | 0.333333 | 0.25 |
| On-Treatment QA | 6 | 5 | 4 | 1 | 0.5 | 0.333333 |
| Treatment Delivery | 5 | 6 | 3 | 2 | 1 | 0.5 |
| Sporadic QA | 6 | 7 | 4 | 3 | 2 | 1 |
| SUM | 27 | 23.25 | 12.45 | 6.616667 | 4.2 | 2.392857 |
| Item | Undeliverable | 1st QA | Pre-Treatment | On-Treatment QA | Treatment Delivery | Sporadic QA | Weight |
|---|---|---|---|---|---|---|---|
| Undeliverable | 0.03703 | 0.01075 | 0.01606 | 0.02519 | 0.04762 | 0.06965 | 3.44% |
| 1st QA | 0.14815 | 0.043011 | 0.02008 | 0.03022 | 0.03968 | 0.05970 | 5.68% |
| Pre-Treatment | 0.18519 | 0.172043 | 0.08032 | 0.03778 | 0.07937 | 0.10448 | 11% |
| On-Treatment QA | 0.22222 | 0.21505 | 0.32129 | 0.15113 | 0.11904 | 0.1393 | 19.5% |
| Treatment Delivery | 0.18519 | 0.25807 | 0.24096 | 0.30227 | 0.2381 | 0.20896 | 23.9% |
| Sporadic QA | 0.22222 | 0.30108 | 0.32129 | 0.4534 | 0.4762 | 0.4179 | 36.5% |
| Sum of columns Normalize and calculate first normalized principal Elgen vector x1 | |
| Calculate the largest Elgen value | |
| Calculate Consistency Index | |
| Verify Consistency Ratio <10% | |
| n | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RI | 0 | 0 | 0.58 | 0.9 | 1.12 | 1.24 | 1.32 | 1.41 | 1.45 | 1.49 | 1.51 | 1.54 | 1.56 | 1.57 | 1.59 |